Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress

d findings from an OSU clinical study that indicated that a

SELDI-TOF-based TTP diagnostic test, which already has been

commercially launched as a laboratory developed test by the

institution, also could be used to help estimate the risk of TTP

relapses during clinical remission. The data -- published in the

online edition of the British Journal of Haematology -- indicate

that use of the test may provide a novel screening strategy to

identify patients who may benefit from prophylactic treatment to

help prevent relapse of this serious blood disorder.

-- Corporate Developments

* Appointed John F. Hamilton, former vice president and chief

financial officer of Depomed, Inc., to the Vermillion Board of

Directors and to serve as chairman of the Audit Committee of the


* Received issuance of U.S. Patent No. 7,341,838 for the discovery of

novel forms of brain natriuretic peptide (BNP), which could

potentially improve upon the current standard of care in diagnosing

and treating cardiovascular disease. The discovery could ultimately

lead to the development of an improved, next-generation assay that

might provide physicians with additional, valuable information to

stratify patients at risk for cardiovascular disease.

* Renewed a long-standing collaboration with Johns Hopkins University

on the development of novel biomarkers that can be applied toward

disease detection, classification and monitoring of prevalent

cancers, including ovarian, breast and prostate. Vermillion will

have access to exclusive commercial rights to the discoveries made

through the partnership.

* Vermillion's stockholders and board of directors approved a 1 for


SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
(Date:8/27/2014)... City, OR (PRWEB) August 27, 2014 ... Report, “Consolidation continues to reshape the look and feel ... nutrition. Consumer demand for higher-quality ingredients will push for ... North American market have experienced strong market growth in ... ethical attributes in their food and cosmetics to fit ...
(Date:8/26/2014)... what they believe is the thinnest-possible semiconductor, a ... only three atoms thick. , The University of ... single-layer semiconductor materials can be connected in an ... result could be the basis for next-generation flexible ... and solar technologies. , "Heterojunctions are fundamental elements ...
(Date:8/26/2014)... MA (PRWEB) August 26, 2014 The ... Faces of ALS (YFALS) community issued the following statement ... movement bringing awareness and driving new funding specifically for ... bucket of water and some ice would raise all ... together with our families, and on behalf of the ...
(Date:8/26/2014)... An analysis by Replikins, Ltd. of Pubmed data of ... Pubmed, has revealed extensive conservation and sharing of specific ... of specific Replikin gene structures has permitted the formulation ... for the H5N1 influenza vaccine and the Taura Syndrome ... be effective (1,2). This Dengue vaccine ...
Breaking Biology Technology:Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4
... , NEW ORLEANS, Dec. 8 HemaQuest Pharmaceuticals ... clinical trials of its lead drug candidate, HQK-1001, in sickle ... the American Society of Hematology in New Orleans. The ... a range of therapeutic agents that have been used in ...
... ... Hearing Aid. , ... (PRWEB) December 8, 2009 -- Whether it’s a crackling fire, jingling sleigh bells, counting down ... on the joyous sounds of the holidays. Lyric, the first 100% invisible extended wear ...
... team led by Yale University scientists has developed a ... the blood using magnetizable liquids. The findings, which will ... online edition of the Proceedings of the National ... and sensitivity of tests used to detect cancer biomarkers, ...
Cached Biology Technology:HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3Lyric Presents the Sounds of the Season 2New technology could boost disease detection tests' speed and sensitivity 2
(Date:8/27/2014)... Outstanding basic research, a growing focus on translating ... care have earned the Herbert Irving Comprehensive Cancer ... and NewYork-Presbyterian Hospital an $18 million, five-year Cancer ... (NCI). The grant renews the center,s status as ... in New York City and one of only ...
(Date:8/27/2014)... the main factors thought to be associated with ... are the age of the patient, mechanism of ... time, repair method, operation technique, and repair materials. ... repair of peripheral nerve injuries, there is no ... prognosis, and the dose-effect relationship of the predictors ...
(Date:8/27/2014)... Warwick research finds , Gamblers show the same ... research has shown. , Researchers, led by Dr Elliot ... conducted tests that found that both human gamblers and ... than low-value rewards. , Published in Biology Letters ... the important role that memories of previous biggest wins ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Gamblers are greedy bird-brains, University of Warwick research finds 2
... aimed at rapid diagnosis of cell death in organs such ... Medical College of Wisconsin to GE Healthcare. Under the ... will have an option to commercialize the technology. The technology, ... Ming Zhao, Ph.D., assistant professor of biophysics. The probes bind ...
... The vomeronasal organ (VNO) is an odor detection system ... located in the VNO, are the initial site of ... transduces chemical signals into electrical signals, however, has been ... Journal of General Physiology ( ), ...
... could cut the lives of disease-carrying mosquitoes in half by ... Now, a new report in the December 24th issue of ... strategy might do one better: The Wolbachia bacteria also makes ... a growing threat to humans, including those responsible for dengue ...
Cached Biology News:GE Healthcare to evaluate and develop novel imaging technology 2New tool in the fight against mosquito-borne disease: A microbial 'mosquito net' 2
Request Info...
... linear ion trap mass spectrometer enables high-throughput ... The LXQ linear ion trap mass spectrometer ... applications, delivering the fast cycle time and ... trap at an attractive price. The ...
... SYBR Safe DNA gel stain was developed specifically ... ethidium bromide for staining DNA in agarose or ... less mutagenic than ethidium bromide but SYBR Safe ... ethidium bromide. SYBR Safe stain comes as a ...
... These are just some the things youll be ... Protein-Protein Interactions, edited by Erica Golemis, One look ... edited compilation of topics in protein interaction will ... that must be a part of your personal ...
Biology Products: